Gabriele M Cerrone insider trades: Tiziana Life Sciences (TLSA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gabriele reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | TLSA | ↑ Buy | 42,357 | $0.99 | $42K | Via Panetta Partners Limited | Aug 7, 2026 (17d) |
| Jul 21, 2026 | OKYO | ↑ Buy | 22,500 | $1.45 | $33K | Via Panetta Partners Limited | Aug 7, 2026 (17d) |
| Jul 20, 2026 | OKYO | ↑ Buy | 25,000 | $1.40 | $35K | Via Panetta Partners Limited | Aug 7, 2026 (18d) |
| Jun 12, 2026 | TLSA | ↑ Buy | 15,000 | $1.11 | $17K | Via Panetta Partners Limited | Aug 7, 2026 (56d) |
| Jun 13, 2025 | ACUT | ↑ Buy | 2,400 | $1.02 | $2K | Via Panetta Partners Limited | Jun 16, 2025 (3d) |
| Jun 12, 2025 | ACUT | ↑ Buy | 37,196 | $0.50 | $18K | Via Panetta Partners Limited | Jun 13, 2025 (1d) |
| Apr 9, 2025 | ACUT | ↑ Buy | 38,000 | $0.67 | $25K | Via Panetta Partners Limited | Apr 10, 2025 (1d) |
| Apr 7, 2025 | ACUT | ↑ Buy | 152,802 | $0.51 | $78K | Via Panetta Partners Limited | Apr 8, 2025 (1d) |
| Dec 31, 2024 | ACUT | ↑ Buy | 100,000 | $0.38 | $38K | Via Panetta Partners Limited | Jan 3, 2025 (3d) |
| Dec 30, 2022 | ACUT | ↑ Buy | 5,000 | $1.40 | $7K | Via Panetta Partners Limited and Planwis | Jan 3, 2023 (4d) |
| Dec 2, 2022 | ACUT | ↑ Buy | 3,729 | $1.42 | $5K | Via Panetta Partners Limited and Planwis | Dec 5, 2022 (3d) |
| Nov 18, 2022 | ACUT | ↑ Buy | 24,500 | $1.05 | $26K | Via Panetta Partners Limited and Planwis | Nov 22, 2022 (4d) |
| Aug 1, 2022 | ACUT | ↑ Buy | 10,000 | $0.79 | $8K | Via Panetta Partners Limited and Planwis | Aug 2, 2022 (1d) |
| Jun 8, 2022 | ACUT | ↑ Buy | 20,000 | $0.50 | $10K | Via Panetta Partners Limited and Planwis | Jun 9, 2022 (1d) |
| May 19, 2022 | OKYO | ↑ Buy | 5,800,000 | $0.08 | $441K | Via Panetta Partners Limited | May 20, 2022 (1d) |
| May 19, 2022 | OKYO | ↑ Buy | 37,500 | $4.00 | $150K | Via Panetta Partners Limited | May 19, 2022 (0d) |
| May 17, 2022 | OKYO | ↑ Buy | 1,625,000 | $0.06 | $97K | Via Panetta Partners Limited | May 18, 2022 (1d) |
| Apr 26, 2022 | ACUT | ↑ Buy | 9,447 | $1.43 | $13K | Via Panetta Partners Limited and Planwis | Apr 27, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLSA insiders
Open-market trades in the last 12 months
About Gabriele M Cerrone's insider trades
Gabriele M Cerrone is a director at Tiziana Life Sciences (TLSA). Since Apr 26, 2022, Gabriele has reported 18 open-market purchases worth $1.0M and no sales on SEC Form 4. In the last 12 months: 4 buys ($126K).
Their filings also include grants and awards (5 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.